Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Presynaptic inhibition of the release of multiple major central nervous system neurotransmitter types by the inhaled anaesthetic isoflurane.

Westphalen RI, Desai KM, Hemmings HC Jr.

Br J Anaesth. 2013 Apr;110(4):592-9. doi: 10.1093/bja/aes448. Epub 2012 Dec 4.

2.

Regional differences in the effects of isoflurane on neurotransmitter release.

Westphalen RI, Kwak NB, Daniels K, Hemmings HC Jr.

Neuropharmacology. 2011 Sep;61(4):699-706. doi: 10.1016/j.neuropharm.2011.05.013. Epub 2011 May 30.

3.

AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release.

Bendor J, Lizardi-Ortiz JE, Westphalen RI, Brandstetter M, Hemmings HC Jr, Sulzer D, Flajolet M, Greengard P.

EMBO J. 2010 Aug 18;29(16):2813-26. doi: 10.1038/emboj.2010.154. Epub 2010 Jul 27.

4.

Regional differences in nerve terminal Na+ channel subtype expression and Na+ channel-dependent glutamate and GABA release in rat CNS.

Westphalen RI, Yu J, Krivitski M, Jih TY, Hemmings HC Jr.

J Neurochem. 2010 Jun;113(6):1611-20. doi: 10.1111/j.1471-4159.2010.06722.x. Epub 2010 Mar 29.

5.

Nicotinic receptor-evoked hippocampal norepinephrine release is highly sensitive to inhibition by isoflurane.

Westphalen RI, Gomez RS, Hemmings HC Jr.

Br J Anaesth. 2009 Mar;102(3):355-60. doi: 10.1093/bja/aen387. Epub 2009 Feb 2.

6.

Reduced inhibition of cortical glutamate and GABA release by halothane in mice lacking the K+ channel, TREK-1.

Westphalen RI, Krivitski M, Amarosa A, Guy N, Hemmings HC Jr.

Br J Pharmacol. 2007 Nov;152(6):939-45. Epub 2007 Sep 10.

7.

The anxiety-like phenotype of 5-HT receptor null mice is associated with genetic background-specific perturbations in the prefrontal cortex GABA-glutamate system.

Bruening S, Oh E, Hetzenauer A, Escobar-Alvarez S, Westphalen RI, Hemmings HC Jr, Singewald N, Shippenberg T, Toth M.

J Neurochem. 2006 Nov;99(3):892-9. Epub 2006 Aug 21.

8.

Volatile anesthetic effects on glutamate versus GABA release from isolated rat cortical nerve terminals: basal release.

Westphalen RI, Hemmings HC Jr.

J Pharmacol Exp Ther. 2006 Jan;316(1):208-15. Epub 2005 Sep 20.

PMID:
16174801
9.

Volatile anesthetic effects on glutamate versus GABA release from isolated rat cortical nerve terminals: 4-aminopyridine-evoked release.

Westphalen RI, Hemmings HC Jr.

J Pharmacol Exp Ther. 2006 Jan;316(1):216-23. Epub 2005 Sep 20.

PMID:
16174800
10.

The identification and characterization of excitotoxic nerve-endings in Alzheimer disease.

Tannenberg RK, Scott HL, Westphalen RI, Dodd PR.

Curr Alzheimer Res. 2004 Feb;1(1):11-25. Review.

PMID:
15975081
11.

The general anesthetic isoflurane depresses synaptic vesicle exocytosis.

Hemmings HC Jr, Yan W, Westphalen RI, Ryan TA.

Mol Pharmacol. 2005 May;67(5):1591-9. Epub 2005 Feb 22.

PMID:
15728262
12.

Synaptic vesicle transport and synaptic membrane transporter sites in excitatory amino acid nerve terminals in Alzheimer disease.

Westphalen RI, Scott HL, Dodd PR.

J Neural Transm (Vienna). 2003 Sep;110(9):1013-27.

PMID:
12938024
13.

Selective depression by general anesthetics of glutamate versus GABA release from isolated cortical nerve terminals.

Westphalen RI, Hemmings HC Jr.

J Pharmacol Exp Ther. 2003 Mar;304(3):1188-96.

PMID:
12604696
14.

Effects of isoflurane and propofol on glutamate and GABA transporters in isolated cortical nerve terminals.

Westphalen RI, Hemmings HC Jr.

Anesthesiology. 2003 Feb;98(2):364-72.

PMID:
12552195
15.

General anesthetics do not affect release of the neuropeptide cholecystokinin from isolated rat cortical nerve terminals.

Pashkov VN, Westphalen RI, Hemmings HC Jr.

Anesthesiology. 2002 Dec;97(6):1500-6.

PMID:
12459677
17.
18.

The nature of d,l-fenfluramine-induced 5-HT reuptake transporter loss in rats.

Westphalen RI, Dodd PR.

Mol Neurobiol. 1995 Aug-Dec;11(1-3):165-75.

PMID:
8561960
19.

Excitotoxic mechanisms in the pathogenesis of dementia.

Dodd PR, Scott HL, Westphalen RI.

Neurochem Int. 1994 Sep;25(3):203-19. Review.

PMID:
7833789
20.

The regeneration of d,l-fenfluramine-destroyed serotonergic nerve terminals.

Westphalen RI, Dodd PR.

Eur J Pharmacol. 1993 Jul 20;238(2-3):399-402.

PMID:
8405109
21.

New evidence for a loss of serotonergic nerve terminals in rats treated with d,l-fenfluramine.

Westphalen RI, Dodd PR.

Pharmacol Toxicol. 1993 Apr-May;72(4-5):249-55.

PMID:
8372042

Supplemental Content

Loading ...
Support Center